Atorvastatin Safety Reappraised: From Pharmacogenomic Mechanisms to Personalized Risk Management

More on Lipid and ceramide metabolism

• Cumulative non-HDL cholesterol links to cardiovascular risk

  Journal of Diabetes and Metabolic Disorders · 4 Oct 2026

• NMR metabolomics improves prediction of cardiometabolic diseases

  medRxiv · 4 Oct 2026

• Cardiovascular risk from metabolic burden weakens with age

  The Lancet Regional Health Western Pacific · 4 Oct 2026

• Early statin use links to lower dementia risk in diabetes

  The Lancet Regional Health Europe · 4 Oct 2026